147 related articles for article (PubMed ID: 27789077)
1. Local Efficacy and Survival after Microwave Ablation of Lung Tumors: A Retrospective Study in 183 Patients.
Zheng A; Ye X; Yang X; Huang G; Gai Y
J Vasc Interv Radiol; 2016 Dec; 27(12):1806-1814. PubMed ID: 27789077
[TBL] [Abstract][Full Text] [Related]
2. Microwave Ablation for Lung Neoplasms: A Retrospective Analysis of Long-Term Results.
Healey TT; March BT; Baird G; Dupuy DE
J Vasc Interv Radiol; 2017 Feb; 28(2):206-211. PubMed ID: 27993505
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of medium-sized hepatocellular carcinoma treated with microwave ablation.
Sun AX; Cheng ZL; Wu PP; Sheng YH; Qu XJ; Lu W; Zhao CG; Qian GJ
World J Gastroenterol; 2015 Mar; 21(10):2997-3004. PubMed ID: 25780298
[TBL] [Abstract][Full Text] [Related]
5. Thermal Ablation of Colorectal Lung Metastases: Retrospective Comparison Among Laser-Induced Thermotherapy, Radiofrequency Ablation, and Microwave Ablation.
Vogl TJ; Eckert R; Naguib NN; Beeres M; Gruber-Rouh T; Nour-Eldin NA
AJR Am J Roentgenol; 2016 Dec; 207(6):1340-1349. PubMed ID: 27680945
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous Cryoablation for the Treatment of Primary and Metastatic Lung Tumors: Identification of Risk Factors for Recurrence and Major Complications.
McDevitt JL; Mouli SK; Nemcek AA; Lewandowski RJ; Salem R; Sato KT
J Vasc Interv Radiol; 2016 Sep; 27(9):1371-1379. PubMed ID: 27321886
[TBL] [Abstract][Full Text] [Related]
7. Microwave versus Radiofrequency Ablation Treatment for Hepatocellular Carcinoma: A Comparison of Efficacy at a Single Center.
Potretzke TA; Ziemlewicz TJ; Hinshaw JL; Lubner MG; Wells SA; Brace CL; Agarwal P; Lee FT
J Vasc Interv Radiol; 2016 May; 27(5):631-8. PubMed ID: 27017124
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Local Progression after Percutaneous Radiofrequency Ablation of Lung Tumors: Evaluation Based on a Review of 147 Tumors.
Yang Q; Qi H; Zhang R; Wan C; Song Z; Zhang L; Fan W
J Vasc Interv Radiol; 2017 Apr; 28(4):481-489. PubMed ID: 28111196
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous High-Energy Microwave Ablation for the Treatment of Pulmonary Tumors: A Retrospective Single-Center Experience.
Egashira Y; Singh S; Bandula S; Illing R
J Vasc Interv Radiol; 2016 Apr; 27(4):474-9. PubMed ID: 26944360
[TBL] [Abstract][Full Text] [Related]
10. Combination Therapies in the Management of Large (≥ 5 cm) Hepatocellular Carcinoma: Microwave Ablation Immediately Followed by Transarterial Chemoembolization.
Si ZM; Wang GZ; Qian S; Qu XD; Yan ZP; Liu R; Wang JH
J Vasc Interv Radiol; 2016 Oct; 27(10):1577-83. PubMed ID: 27103146
[TBL] [Abstract][Full Text] [Related]
11. Patients' survival in lung malignancies treated by microwave ablation: our experience on 56 patients.
Belfiore G; Ronza F; Belfiore MP; Serao N; di Ronza G; Grassi R; Rotondo A
Eur J Radiol; 2013 Jan; 82(1):177-81. PubMed ID: 23099201
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.
Simon CJ; Dupuy DE; DiPetrillo TA; Safran HP; Grieco CA; Ng T; Mayo-Smith WW
Radiology; 2007 Apr; 243(1):268-75. PubMed ID: 17392258
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Percutaneous Microwave Hepatic Ablation Near the Heart.
Carberry GA; Smolock AR; Cristescu M; Wells SA; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Brace CL; Lee FT
J Vasc Interv Radiol; 2017 Apr; 28(4):490-497. PubMed ID: 28190707
[TBL] [Abstract][Full Text] [Related]
14. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
[TBL] [Abstract][Full Text] [Related]
15. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
16. Preliminary Outcome of Microwave Ablation of Hepatocellular Carcinoma: Breaking the 3-cm Barrier?
Thamtorawat S; Hicks RM; Yu J; Siripongsakun S; Lin WC; Raman SS; McWilliams JP; Douek M; Bahrami S; Lu DS
J Vasc Interv Radiol; 2016 May; 27(5):623-30. PubMed ID: 27013403
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of vascular and lymphovascular invasion in early lung cancer.
Al-Alao BS; Gately K; Nicholson S; McGovern E; Young VK; O'Byrne KJ
Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):55-64. PubMed ID: 24585645
[TBL] [Abstract][Full Text] [Related]
19. Local control, safety, and survival following image-guided percutaneous microwave thermal ablation in primary lung malignancy.
Tsakok MT; Little MW; Hynes G; Millington RS; Boardman P; Gleeson FV; Anderson EM
Clin Radiol; 2019 Jan; 74(1):80.e19-80.e26. PubMed ID: 30447997
[TBL] [Abstract][Full Text] [Related]
20. Defining New Metrics in Microwave Ablation of Pulmonary Tumors: Ablation Work and Ablation Resistance Score.
Al-Hakim RA; Abtin FG; Genshaft SJ; Kutay E; Suh RD
J Vasc Interv Radiol; 2016 Sep; 27(9):1380-1386. PubMed ID: 27566426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
